Clinical characteristics and outcomes of macrophage activation syndrome among patients attending a rheumatology tertiary care center in North India
Background: Macrophage activation syndrome (MAS) is a potentially fatal condition complicating several rheumatologic disorders. This retrospective analysis studied the clinical characteristics and outcomes of patients diagnosed with MAS from a rheumatology tertiary care center. Methods: Pediatric an...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2022-01-01
|
| Series: | Indian Journal of Rheumatology |
| Subjects: | |
| Online Access: | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2022;volume=17;issue=2;spage=149;epage=152;aulast= |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841561334416670720 |
|---|---|
| author | Rasmi Ranjan Sahoo Manesh Manoj Prashant Bafna Kasturi Hazarika Anupam Wakhlu |
| author_facet | Rasmi Ranjan Sahoo Manesh Manoj Prashant Bafna Kasturi Hazarika Anupam Wakhlu |
| author_sort | Rasmi Ranjan Sahoo |
| collection | DOAJ |
| description | Background: Macrophage activation syndrome (MAS) is a potentially fatal condition complicating several rheumatologic disorders. This retrospective analysis studied the clinical characteristics and outcomes of patients diagnosed with MAS from a rheumatology tertiary care center.
Methods: Pediatric and adult patients diagnosed with rheumatologic disorders and fulfilling the 2016 European League against Rheumatism/American College of Rheumatology classification criteria for MAS associated with systemic juvenile idiopathic arthritis (sJIA) or the hemophagocytic lymphohistiocytosis (2004) criteria, as appropriate, were included over a period of 1 year. Detailed clinical history and laboratory parameters were extracted from the patients' records. Treatment details, duration of hospitalization, and outcomes were recorded.
Results: The study included nine patients (five males and four females) with a median age of 27 years, range 10–48 years. The median duration of illness was 6 months, range 2–60 months. Five patients were diagnosed with systemic lupus erythematosus, two patients with adult-onset Still's disease, and one each with sJIA and sarcoidosis. Infection (three patients), malignancy (one patient), and uncontrolled or aggressive disease (five patients) were recognized as the possible precipitating factors. Three patients had pancytopenia at presentation, whereas bicytopenia was observed in five patients. Hemophagocytosis on bone marrow biopsy was seen in seven patients. The median duration of hospital stay was 3 weeks, range 2–4 weeks. High-dose steroids were administered to all patients, along with oral cyclosporine in seven patients. One patient was given weekly etoposide infusion for unabated MAS. Two patients expired.
Conclusion: Prompt diagnosis and aggressive treatment strategy are pivotal for improving prognosis in MAS complicating rheumatologic disorders. |
| format | Article |
| id | doaj-art-5b95ba4627e94162aaadf4fcdf245cad |
| institution | Kabale University |
| issn | 0973-3698 0973-3701 |
| language | English |
| publishDate | 2022-01-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Indian Journal of Rheumatology |
| spelling | doaj-art-5b95ba4627e94162aaadf4fcdf245cad2025-01-03T01:45:47ZengSAGE PublishingIndian Journal of Rheumatology0973-36980973-37012022-01-0117214915210.4103/injr.injr_70_21Clinical characteristics and outcomes of macrophage activation syndrome among patients attending a rheumatology tertiary care center in North IndiaRasmi Ranjan SahooManesh ManojPrashant BafnaKasturi HazarikaAnupam WakhluBackground: Macrophage activation syndrome (MAS) is a potentially fatal condition complicating several rheumatologic disorders. This retrospective analysis studied the clinical characteristics and outcomes of patients diagnosed with MAS from a rheumatology tertiary care center. Methods: Pediatric and adult patients diagnosed with rheumatologic disorders and fulfilling the 2016 European League against Rheumatism/American College of Rheumatology classification criteria for MAS associated with systemic juvenile idiopathic arthritis (sJIA) or the hemophagocytic lymphohistiocytosis (2004) criteria, as appropriate, were included over a period of 1 year. Detailed clinical history and laboratory parameters were extracted from the patients' records. Treatment details, duration of hospitalization, and outcomes were recorded. Results: The study included nine patients (five males and four females) with a median age of 27 years, range 10–48 years. The median duration of illness was 6 months, range 2–60 months. Five patients were diagnosed with systemic lupus erythematosus, two patients with adult-onset Still's disease, and one each with sJIA and sarcoidosis. Infection (three patients), malignancy (one patient), and uncontrolled or aggressive disease (five patients) were recognized as the possible precipitating factors. Three patients had pancytopenia at presentation, whereas bicytopenia was observed in five patients. Hemophagocytosis on bone marrow biopsy was seen in seven patients. The median duration of hospital stay was 3 weeks, range 2–4 weeks. High-dose steroids were administered to all patients, along with oral cyclosporine in seven patients. One patient was given weekly etoposide infusion for unabated MAS. Two patients expired. Conclusion: Prompt diagnosis and aggressive treatment strategy are pivotal for improving prognosis in MAS complicating rheumatologic disorders.http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2022;volume=17;issue=2;spage=149;epage=152;aulast=adult onsethemophagocyticlymphohistiocytosisrheumatic diseases; still's disease |
| spellingShingle | Rasmi Ranjan Sahoo Manesh Manoj Prashant Bafna Kasturi Hazarika Anupam Wakhlu Clinical characteristics and outcomes of macrophage activation syndrome among patients attending a rheumatology tertiary care center in North India Indian Journal of Rheumatology adult onset hemophagocytic lymphohistiocytosis rheumatic diseases; still's disease |
| title | Clinical characteristics and outcomes of macrophage activation syndrome among patients attending a rheumatology tertiary care center in North India |
| title_full | Clinical characteristics and outcomes of macrophage activation syndrome among patients attending a rheumatology tertiary care center in North India |
| title_fullStr | Clinical characteristics and outcomes of macrophage activation syndrome among patients attending a rheumatology tertiary care center in North India |
| title_full_unstemmed | Clinical characteristics and outcomes of macrophage activation syndrome among patients attending a rheumatology tertiary care center in North India |
| title_short | Clinical characteristics and outcomes of macrophage activation syndrome among patients attending a rheumatology tertiary care center in North India |
| title_sort | clinical characteristics and outcomes of macrophage activation syndrome among patients attending a rheumatology tertiary care center in north india |
| topic | adult onset hemophagocytic lymphohistiocytosis rheumatic diseases; still's disease |
| url | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2022;volume=17;issue=2;spage=149;epage=152;aulast= |
| work_keys_str_mv | AT rasmiranjansahoo clinicalcharacteristicsandoutcomesofmacrophageactivationsyndromeamongpatientsattendingarheumatologytertiarycarecenterinnorthindia AT maneshmanoj clinicalcharacteristicsandoutcomesofmacrophageactivationsyndromeamongpatientsattendingarheumatologytertiarycarecenterinnorthindia AT prashantbafna clinicalcharacteristicsandoutcomesofmacrophageactivationsyndromeamongpatientsattendingarheumatologytertiarycarecenterinnorthindia AT kasturihazarika clinicalcharacteristicsandoutcomesofmacrophageactivationsyndromeamongpatientsattendingarheumatologytertiarycarecenterinnorthindia AT anupamwakhlu clinicalcharacteristicsandoutcomesofmacrophageactivationsyndromeamongpatientsattendingarheumatologytertiarycarecenterinnorthindia |